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Differential scanning calorimetryA central tenet of the lipid raft model is the existence of non-raft domains. In support of this view, we have
established in model membranes that a phosphatidylethanolamine (PE)-containing docosahexaenoic acid
(DHA) forms organizationally distinct non-raft domains in the presence of sphingomyelin (SM) and
cholesterol (Chol). We have shown that formation of DHA-rich domains is driven by unfavorable molecular
interactions between the rigid Chol molecule and the highly ﬂexible DHA acyl chain. However, the molecular
interactions between SM and the DHA-containing PE, which could also contribute to the formation of DHA-
rich non-raft domains, have not been sufﬁciently investigated. To address this issue, we use differential
scanning calorimetry (DSC) to study the phase behavior of mixtures of SM with either 1-palmitoyl-2-
docosahexaenoyl-sn-glycero-3-phosphoethanolamine (16:0-22:6PE) or 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (16:0-18:1PE), an oleic acid (OA)-containing control, over a wide range of
concentrations. Deconvolution of binary DSC scans shows that both 16:0-22:6PE and 16:0-18:1PE phase
separate from SM. Analysis of transition temperatures and partial phase diagrams, constructed from the DSC
scans for the ﬁrst time, shows that 16:0-22:6PE displays greater non-ideal mixing with SM compared to
16:0-18:1PE. Our ﬁndings support a model in which DHA- and OA-containing PEs differentially phase
separate from SM over a wide range of molar ratios to initiate the formation of non-raft domains, which is
greatly enhanced by DHA, but not OA, in the presence of cholesterol.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Docosahexaenoic acid (DHA, 22:6) is an n-3 polyunsaturated fatty
acid (PUFA) that is increasingly consumed as a food supplement by
the general public and is also being tested clinically for the treatment
of speciﬁc human ailments [1,2]. Most notably, DHA is documented to
provide some beneﬁcial effects for the treatment of speciﬁc symptoms
associated with autoimmune and inﬂammatory disorders [3,4].
However, effective use of DHA as a food additive or as a therapeutic
agent has been limited by poor understanding of its mode of action at
the molecular level.
One emerging view is that DHA-containing phospholipids
modify the biophysical organization of the plasma membrane,
which in turn modiﬁes protein activity and cellular function [5-10].
This possible mechanism has a broad impact given that dietary
intake of DHA can increase incorporation of the fatty acid into the
sn-2 position of the major membrane phospholipids, phosphatidyl-+1 252 744 3383.
ll rights reserved.choline (PC) and phosphatidylethanolamine (PE), by up to 8-fold
[11]. In support of a role for DHA in membrane organization, we
have established that the heteroacid phospholipid 16:0-22:6PE,
with palmitic acid in the sn-1 chain and DHA in the sn-2 chain,
forms domains that are organizationally distinct from sphingomye-
lin (SM)- and cholesterol (Chol)-rich lipid rafts [12-15]. While
tremendous attention has been given to SM/Chol-rich lipid rafts,
which serve to compartmentalize cellular signaling events, very
little is known about the composition, function or even existence of
non-raft domains [9,16-18].
Using several biophysical methods, we have found that phase
separation of 16:0-22:6PE from lipid rafts is driven by unfavorable
interactions between the DHA acyl chain and Chol [15,19]. X-ray
diffraction measurements, supported by solid state 2H NMR, show the
highly disordered structure of DHA is sterically incompatible with the
rigid steroid moiety of Chol [19]. In contrast, 16:0-18:1PE, containing
the monounsaturated oleic acid (OA), does not phase separate from
SM and Chol to the same extent because themore ordered structure of
OA allows close proximity to the sterol [20]. A key point that we have
not thoroughly investigated in our model is the molecular relation-
ship between SM and PE. Initially, we inferred from differential
Fig. 1. Deconvolution of multicomponent DSC scans. Sample DSC scan of SM with
0.7 mol fraction 16:0-18:1PE. Deconvolution of the scan (solid line), as described in
Materials and Methods, allowed the assignment of a SM-rich phase melting at higher
temperature and a 16:0-18:1PE-rich phase melting at lower temperature (dashed
lines). For each phase, we determined the transition temperature (Tm), which is the
mid-point of the Gaussian curve. The onset and completion temperatures were
identiﬁed as the point at which the peak begins to emerge above the baseline or returns
to the baseline, respectively.
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phase separates from SM [21]. More recently, data from our
laboratories indicate that both 16:0-22:6PE and 16:0-18:1PE can
phase separate from SM in the absence of Chol, contradictory to our
initial interpretation [12,13]. To resolve this discrepancy, here we
initiated a study comparing the phase behavior of 16:0-22:6PE vs.
16:0-18:1PE in mixtures with SM over a wide range of mol fractions.
Using DSC, we ﬁnd that both PEs do indeed phase separate from SM.
However, there are differences in the phase behavior of 16:0-18:1PE/
SM versus 16:0-22:6PE/SM. Phase diagrams for SM/16:0-22:6PE and
SM/16:0-18:1PE mixtures, constructed from DSC scans, for the ﬁrst
time, conﬁrm greater immiscibility for DHA- over an OA-containing
PE with SM.
2. Materials and methods
2.1. Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (16:0-
18:1PE), 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphoetha-
nolamine (16:0-22:6PE) and egg sphingomyelin (SM) were pur-
chased from Avanti Polar Lipids (Alabaster, AL). The concentration of
lipid stock solutions was quantiﬁed using phosphate analyses [13].
Lipid purity was assessed with thin layer chromatography (TLC) on
high performance TLC plates (Alltech, Deerﬁeld, IL). Water for buffer
solutions was deionized, glass distilled and further puriﬁed with a
Milli-Q system (Millipore, Bedford, MA) prior to use.
2.2. Differential scanning calorimetry (DSC)
DSC samples were prepared taking stringent precautions to
prevent oxidation. As described before, the precautions entailed
preparing samples under low light conditions in a glove box ﬁlled
with nitrogen gas [12,13,21]. All lipid mixtures were co-dissolved in
HPLC grade chloroform (Sigma, St. Louis, MO) and evaporated
under a gentle stream of argon gas and subsequently placed in a
vacuum pump overnight to remove residual organic solvent. The
dried lipid mixtures (5 mg) were then mixed with 1 ml of 10 mM
sodium phosphate buffer (pH 7.0) above the phase transition
temperature (Tm) of sphingomyelin (N38 °C), the lipid in the
mixture with the highest Tm, in order to ensure complete
hydration. The resultant aqueous suspensions were frozen on dry
ice and thawed three times in a water bath above the Tm of the
lipids. Samples (500 μl) were degassed and placed into the three
chambers of a Calorimetry Sciences DSC (American Fork, UT) while
the fourth chamber (reference) contained 500 μl of buffer. All
measurements were made at a scan rate of 0.125 °C/min.
Consecutive heating and cooling scans were acquired and analyzed.
They exhibited negligible hysteresis and, consistent with our
previous reports [12,13,21], only the cooling scans are presented.
Control samples of 16:0-16:0PC were routinely run to ensure
instrument calibration.
2.3. Analysis
All deconvolutions of the multicomponent scans after baseline
correction were conducted using Microcal Origin software as
described recently [12]. The strategy employed is elaborated in
Fig. 1. Tms for a given solid to ﬂuid transition are deﬁned as the
midpoint of the associated peak in the scan. Enthalpies for the pure
components were determined by integrating the curves.
Ideal phase diagrams were constructed as described by Mabrey
and Sturtevant [22], with the following equations:
Χ lð ÞB = 1− αð Þ= β − αð Þ; Χ sð ÞB = βΧ lð ÞB ð1Þwhere the superscripts (l) and (s) for a given mol fraction (X) refer to
the liquidus and solidus curves, respectively. The quantities α and β
are deﬁned for a given temperature T as follows:
α = exp
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R
1
T
− 1
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  
; β = exp
ΔHB
R
1
T
− 1
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where ΔHA and ΔHB are the enthalpy of the pure lipids A and B, and TA
and TB are their absolute transition temperatures [22].
Construction of the phase diagram from experimental data
required determination of the onset and completion temperatures
for each deconvoluted peak. In Fig. 1, we show how these
temperatures were determined. All data reported are from two to
four independent measurements and are plotted as the average±SE.
3. Results
3.1. SM/16:0-18:1PE phase behavior
Weutilized DSC to ﬁrst investigate the phase behavior of SM/16:0-
18:1PE mixtures. Fig. 2A shows cooling scans for SM/16:0-18:1PE
with increasing mol fraction of 16:0-18:1PE (χPE). With the addition
of 0.1–0.4 mol fraction 16:0-18:1PE, we ﬁnd a single transition peak
that is asymmetric towards the low temperature side (indicated by an
arrow) and that we interpret in terms of two overlapping transitions.
In the presence of 0.5–0.8 mol fraction 16:0-18:1PE, we observe a
single asymmetric transition peak with a shoulder on the high
temperature side (indicated by an arrow) that we interpret as the
presence of two components. We deconvoluted the measured
transition into two transitions that, based on the Tms for the pure
lipid components, we ascribe to a 16:0-18:1PE-rich phase melting at
lower temperature and to a SM-rich phase melting at higher
temperature. For 0.9 mol fraction 16:0-18:1PE, an obvious shoulder
is no longer apparent in the transition that we assign to the melting of
a single 16:0-18:1PE-rich phase.
In Fig. 2B, Tms measured from the DSC scans in Fig. 2A for the
16:0-18:1PE-rich and SM-rich phases are plotted against mol
fraction of 16:0-18:1PE. The ﬁrst detectable phase transition
Fig. 2. Phase behavior of SM/16:0-18:1PE. (A) DSC cooling scans recorded for SM with
increasing mol fraction 16:0-18:1PE. Arrows indicate the presence of a second phase
transition. The data are a single set of experiments representative of two to four
independent measurements. (B) Phase transition temperature (average±SE) for the
16:0-18:1PE-rich (open circles) and SM-rich (closed squares) phases as a function of
mol fraction of 16:0-18:1PE. The solid lines are sigmoidal ﬁts to the data.
Fig. 3. Phase behavior of SM/16:0-22:6PE. (A) DSC cooling scans recorded for SM with
increasing mol fraction 16:0-22:6PE. Arrows indicate the presence of a second phase
transition. The data are a single set of experiments representative of two to four
independent measurements. (B) Phase transition temperature (average±SE) for the
16:0-22:6PE (open circles) and SM-rich (closed squares) phases as a function of mol
fraction of 16:0-22:6PE. The solid lines are linear ﬁts to the data.
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Tms for this phase decrease up to mol fraction 0.4 and then remain
constant with further increase in χPE (Fig. 2B, open circles). For the
transition attributed to a SM-rich phase, Tms decrease in an
approximately linear fashion up to χPE =0.4 (Fig. 2B, closed
squares). Between χPE=0.4 and 0.8, the Tms for the SM-rich phase
show little change. The transition temperatures measured for pure
16:0-18:1PE and SM bilayers are, respectively, ∼26 °C and ∼39 °C,
consistent with previous reports [12,13].
3.2. SM/16:0-22:6PE phase behavior
DSC cooling scans recorded for mixtures of SM/16:0-22:6PE
mixtures in aqueous dispersion with increasing mol fraction of
16:0-22:6PE are shown in Fig. 3A. They illustrate that because the
transition temperature for SM and PE differs more when the
phospholipid is polyunsaturated, separation into SM- and PE-rich
domains is easier to discern with SM/16:0-22:6PE than with SM/
16:0-18:1PE (compare Fig. 3A to Fig. 2A). Well resolved bimodal
transitions emerge upon the addition of 0.1 mol fraction 16:0-22:6PEand continue up to a mol fraction of 0.8. Although there is
subsequently only a single peak at χPE=0.9, the presence of a
shoulder on the high temperature side indicates that the transition is
still bimodal. We ascribe the transitions at lower and higher
temperature to the melting of 16:0-22:6PE- and SM-rich phases,
respectively. Arrows in Fig. 3A indicate co-existence of two transi-
tions. Deconvolutions were not required for 16:0-22:6PE/SM mix-
tures since two distinct transitions could be observedwithout overlap,
with the exception of χPE=0.9.
Fig. 3B is a plot of Tms obtained for the 16:0-22:6PE- and SM-rich
phases from the DSC scans for SM/16:0-22:6PE mixtures in Fig. 3A
versus mol fraction of 16:0-22:6PE. The transition temperature for the
16:0-22:6PE-rich phase (Fig. 3B, open circles) remains relatively
constant, similar to the 16:0-18:1PE-rich phase (Fig. 2B, open circles)
in SM/16:0-18:1PE mixtures. For the SM-rich phase (Fig. 3B, ﬁlled
squares), the Tms decrease linearly with increasing mol fraction 16:0-
22:6PE. This trend is different from the observation made for the
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mixtures that show an abrupt change in slope at χPE=0.4.
3.3. Phase diagrams reveal 16:0-22:6PE/SM deviates from ideal mixing
more than 16:0-18:1PE/SM
Binary temperature–composition phase diagrams constructed
from the data presented in Figs. 2 and 3 are shown in Fig. 4 for SM/
16:0-18:1PE (top) and SM/16:0-22:6PE (bottom). The experimental
solidus and ﬂuidus boundaries (dotted lines) were determined,
respectively, from the onset and completion temperatures of the
deconvoluted peaks in the DSC curves (Materials andmethods), while
ideal mixing (solid lines) was determined as described byMabrey and
Sturtevant [22].
The phase diagrams illustrate that neither 16:0-18:1PE nor 16:0-
22:6PE mixes ideally with SM. The temperature range over which
solid and ﬂuid phases coexist in the two mixed membrane systems
identiﬁed experimentally exceeds the relatively narrow differential in
temperature between solidus and liquidus lines that were calculated
on the basis of ideal mixing. However, it is clear that the deviationFig. 4. Phase diagrams for SM/16:0-18:1PE (top panel) and SM/16:0-22:6PE (bottom
panel). The ideal solidus and ﬂuidus solid lines were calculated with Eqs. (1) and (2), as
described in Materials and Methods. The experimental solidus and ﬂuidus dashed lines
were generated from the temperature of the onset and completion of the transitions in
DSC scans. Data points are an average±SE from two to four independent measure-
ments. The solid and ﬂuid phases are indicated in each phase diagram.from ideal behavior is accentuated for 16:0-22:6PE relative to 16:0-
18:1PE. The solid to solid+ﬂuid (mixed state) transition for SM/
16:0-18:1PE and SM/16:0-22:6PE generally lies below the solidus
line, but 16:0-22:6PE depresses the temperaturemore and the smaller
depression in temperature seen with 16:0-18:1PE disappears at
χPE≥0.8. The solid+ﬂuid to ﬂuid transition for both systems also
generally lies above the liquidus line, but 16:0-22:6PE elevates the
temperaturemore and the smaller elevation in temperature seenwith
16:0-18:1PE is comparable to or only slightly bigger than experi-
mental uncertainty. Overall, 16:0-18:1PE and 16:0-22:6PE exhibit
immiscibility with SM, which is more pronounced with the DHA-
containing phospholipid.
4. Discussion
In a series of earlier reports, using several biophysical methods, we
have proposed a model for one possible molecular mode of action for
DHA [12,13,15,23]. The proposed model explains how DHA modiﬁes
membrane structure as a mechanism to initiate changes in protein
activity and cellular function [6,9]. In this model, DHA-containing
phospholipids phase separate to form liquid disordered domains,
depleted in Chol, that are compositionally and organizationally
distinct from liquid ordered lipid raft domains enriched in sphingo-
lipids and Chol [10]. From a mechanistic perspective, we have
demonstrated that formation of DHA-rich/Chol-poor domains is
driven by steric incompatibility between the highly disordered DHA
acyl chain and the rigid steroid moiety of Chol [19]. PE, which
incorporates dietary DHAmore than PC, has been the focus of much of
our work [11]. A central question that has remained unanswered in
our model system is: what is the molecular relationship between the
heteroacid DHA-containing PE and SM?
4.1. Resolving contradictory data on SM-PE molecular interactions
Our previous studies compared the molecular interactions of 16:0-
22:6PE vs. 16:0-18:1PE with SM only at equimolar concentration
[12,13,15]. Initially, we interpreted our data to conclude that 16:0-
22:6PE, but not 16:0-18:1PE, phase separated from SM in the absence
of Chol [21]. This assessment reﬂected the difﬁculty in recognizing
that the DSC peak for SM/16:0-18:1PE in 1:1 mol mixture consists of
two closely overlapping transitions (Tm ∼39 °C and ∼26 °C for pure
SM and 16:0-18:1PE, respectively). This experimental problem was
not encountered in the analysis of the DSC scan observed for
equimolar SM/16:0-22:6PE where the two monotectic transitions
occur at very different temperatures (Tm ∼6 °C for pure 16:0-22:6PE).
In contrast, and in agreement with the current work, our recent 2H
NMR spectroscopy experiments determined that both phospholipids
could indeed phase separate from SM [12]. In these studies, analogs of
PE ([2H31]16:0-22:6PE or [2H31]16:0-18:1PE) with a perdeuterated
sn-1 chain and SM ([2H31]-N-palmitoylsphingomyelin, [2H31]16:0SM)
with a perdeuterated amide-linked acyl chain were employed to
probe the molecular organization of each lipid in PE/SM (1:1 mol)
mixtures [12]. The smaller value of average order parameters−SCD that
were derived from spectra recorded at 35 °C for [2H31]16:0-22:6PE vs.
[2H31]16:0SM and [2H31]16:0-18:1PE vs. [2H31]16:0SM in their
respective mixed systems was attributed to the formation of PE-
rich, characterized by lower order, and SM-rich, characterized by
higher order, domains in both DHA- and OA-containing membranes.
Physical insight into the molecular architecture of the domains was
also deduced from the NMR data. A bilayer thickness that is 2–3 Å less
for PE-rich than SM-rich domains was estimated on the basis of the
average length bLN for [2H31]16:0 chains calculated from the −SCD
values. Because only a single spectral component is discernible for
[2H31]16:0-22:6PE, [2H31]16:0-18:1PE or [2H31]16:0SM in the spectra
recorded with SM/PE (1:1 mol) mixtures, despite incomplete
demixing, the domains must be small enough for lipids to laterally
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was then assigned to the size on the basis of the difference in average
quadrupolar splitting in the domains [12].
The purpose of the current study was to further elucidate the
relative ability of DHA- vs. OA (control)-containing phospholipids to
phase separate from SM. To accomplish this objective we extend our
earlier work performed on PE and SM in only equimolar ratio to a
wide concentration range.
4.2. Phase diagrams
The experimental phase diagrams plotted in Fig. 4 show that
although neither 16:0-18:1PE nor 16:0-22:6PE mixes ideally with SM,
the monounsaturated OA-containing PE is more miscible than the
polyunsaturated DHA-containing PE when compared to ideal beha-
vior. The phase diagrams were constructed from DSC scans by
determining the temperature at which a transition peak emerges
above and returns to the baseline. An alternative approach is to
determine the temperature at which an asymptotic line to either side
of the peak intersects the baseline. Employing this approach provides
essentially the same results as shown in Fig. 4 (data not shown). The
only difference is a small shift in the temperature values but does not
affect our appraisal of the difference in miscibility between 16:0-
18:1PE vs. 16:0-22:6PE with SM.
The plots of Tm against χPE for SM/16:0-18:1PE and SM/16:0-
22:6PE mixtures in Figs. 2B and 3B, respectively, demonstrate a
signiﬁcant difference in behavior for OA- vs. DHA-containing systems.
In SM/16:0-18:1PE, Tm for the SM-rich phase decreases approxi-
mately linearly with increasing amount of PE until χPE=0.4 and then
remains virtually constant with higher concentration (Fig. 2B). In SM/
16:0-22:6PE, by contrast, Tm for the SM-rich phase falls in linear
fashion with increasing amount of PE throughout the entire range of
concentration (Fig. 3B). The variation in Tm for the PE-rich phase is
small in comparison for both systems. Our interpretation is that 16:0-
18:1PE is more readily accumulated into SM-rich domains than 16:0-
22:6PE with its highly disordered DHA chain. Whereas the effect on
Tm for the SM-rich phase in the mixed membrane levels off around
χPE=0.4with the OA-containing PE, the corresponding concentration
is not reached with the DHA-containing PE. An alternative view is that
greater phase separation is apparent in SM/16:0-22:6PE because the
difference in transition temperature for the individual lipids is bigger.
Separate transition peaks for PE- and SM-rich phase are then resolved
in the DHA-containing mixed membrane (monotectic behavior) (Fig.
3A), like in the pioneering DSC studies of binary lipid systems
published by Demel et al. [24,25]. In SM/16:0-18:1PE, the transition
temperature for each lipid is much closer and overlapping transitions
(non-monotectic behavior) that require deconvolution are observed
(Fig. 2A).
Phase separation between PE and SM must be driven by
unfavorable interactions between the lipid head groups and/or
between the acyl chains. The head group of PE is small and
complements the larger head group of SM, promoting close contact
between the two lipids. Such a situation is similar to what is observed
with cholesterol and SM [26]. Interactions between the rigid steroid
moiety and the ordered saturated acyl chains of SM are favorable, and
the sterol phase separates with SM into lipid rafts. However, the high
disorder of the DHA chain makes interaction with SM much more
difﬁcult for 16:0-22:6PE, thus driving phase separation. OA is less
disordered than DHA, thus reducing the tendency for 16:0-18:1PE to
separate away from SM.
The presence of discontinuities in the liquidus and solidus curves
in the phase diagrams constructed, particularly for SM/16:0-22:6PE,
is noted (Fig. 4). Their origin is not known. Models invoking the
regular distribution of cholesterol in superlattices in PC bilayers have
been put forward on the basis of kinks or dips in the intensity
recorded with ﬂuorescent probes at critical sterol concentrations[27,28]. Similar evidence that superlattice arrangements exist for PE in
PC/PE membranes has also been published [29].
4.3. Physiological implications
We conclude that 16:0-22:6PE has a greater tendency to phase
separate from SM than does 16:0-18:1PE. The tremendously high
disorder possessed by DHA chains is responsible. The polyunsaturated
chain rapidly isomerizes through its entire conformational space
within 50 ns [30] and pushes away ordered SM molecules. Based on
our previous ﬁndings, phase separation of DHA-containing PE away
from SM is further enhanced upon the addition of Chol [12,13,15]. The
aversion the sterol has for DHA, but not OA, is the reason. As a result,
DHA-rich/Chol-poor domains form, which according to our model
provide an environment that can change the lateral organization and/
or conformation of proteins. Indeed, our in vitro studies have shown
that DHA-containing phospholipids can modify the conformation of
the major histocompatibility complex (MHC) class I protein [31].
Very recent cell culture and ex vivo studies highlight the
physiological relevance of studying the relationship between DHA-
containing phospholipids and their inﬂuence on lipid raft organiza-
tion. For instance, the Shaikh laboratory recently showed that DHA,
but not eicosapentaenoic acid (EPA), diminished lipid raft clustering
and increased raft size in EL4 cells, which modiﬁed MHC class I lateral
organization [32]. The study suggested that changes in lipid raft
organization were driven by the formation of nanometer scale DHA-
rich domains [32]. Similarly, others have also shown that DHA-
containing phospholipids modify lipid raft organization and subse-
quently the lateral organization of several proteins of CD4+ T cells and
breast cancer cells [33-37]. This has functional consequences for
suppressing the activation of T cells associated with inﬂammation or
inducing apoptosis of breast cancer cells [34,35].
4.4. Concluding remarks
Our study shows that both 16:0-18:1PE and 16:0-22:6PE phase
separate from SM; however, 16:0-22:6PE displays greater non-ideal
mixing with SM than 16:0-18:1PE over a wide range of concentra-
tions. The ﬁndings are consistent with our model that shows DHA has
an important role in triggering phase separation into SM/Chol-rich
raft and DHA-rich/Chol-poor non-raft domains. Future studies will
focus on the role of DHA in modifying protein conformation and/or
lateral organization, which we predict will be modiﬁed in response to
the formation of DHA-rich non-raft domains.
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